Ocular Therapeutix shares fall on Q1 miss

This article was originally published here

Ocular Therapeutix Shares in Ocular Therapeutix (NSDQ:OCUL)  fell today after the ophthalmologic device developer posted 1st quarter earnings that missed expectations on Wall Street.

The Bedford, Mass.-based company posted losses of $16 million, or 58¢ per share, on sales of $475,000 for the 3 months ended March 31, seeing losses grow 47.8% while sales grew 14.2% compared with the same period last year.

Read the whole story on our sister site, Drug Delivery Business

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply